Survival probabilities from the time of start of induction therapy (conventional-dose chemotherapy) in 42 patients with newly diagnosed MM. Patients with a p53 deletion (n = 14; solid line) have a significantly shorter survival time compared with MM patients without a p53 deletion (n = 28; dotted line) (P < .0002).